All stocks Β· GIANLIFE
GL

Gian Life Care Limited

GIANLIFE BSE Diagnostics & Research Healthcare

Gian Life Care Limited provides diagnostic and related healthcare tests and services primarily in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services. The company also provides vari…

ISIN INE063601012
Listed β€”
Quarters tracked 13
Filings 11 docs

About

Gian Life Care Limited provides diagnostic and related healthcare tests and services primarily in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services. The company also provides various types of tests, such as biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, etc. It serves patients, healthcare providers, hospitals, and corporate customers. The company was incorporated in 2018 and is based in Kanpur, India.

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022
Sales 1.12 0.66 0.87 1.11 1.59 1.95 1.98 4.60 3.79 2.30 2.43 1.55 5.09
Expenses 0.87 1.05 0.73 1.12 1.11 1.72 1.76 1.49 1.55 1.97 1.92 2.27 2.80
Operating Profit 0.25 -0.39 0.14 -0.01 0.48 0.23 0.22 3.11 2.24 0.33 0.51 -0.72 2.29
OPM % 22.32 -59.09 16.09 -0.90 30.19 11.79 11.11 67.61 59.10 14.35 20.99 -46.45 44.99
Other Income 0.09 0.09 0.15 -0.24 0.16 0.16 0.17 0.18 0.16 0.15 0.14 0.18 0.17
Depreciation 0.11 0.11 0.11 0.11 0.12 0.12 0.12 0.07 0.13 0.13 0.13 0.12 0.14
Interest 0.13 0.09 0.09 0.10 0.10 0.10 0.11 0.11 0.11 0.11 0.12 0.11 0.12
Profit before tax 0.10 -0.50 0.09 -0.46 0.42 0.17 0.16 3.11 2.16 0.24 0.40 -0.77 2.20
Tax % -30.00 -8.00 33.33 4.35 9.52 11.76 37.50 29.26 24.54 16.67 35.00 18.18 13.64
Net Profit 0.12 -0.46 0.05 -0.48 0.38 0.14 0.11 2.20 1.63 0.20 0.26 -0.90 1.89
EPS in Rs 0.12 -0.44 0.05 -0.46 0.37 0.14 0.11 2.13 1.58 0.19 0.25 -0.87 1.83

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales 5.9412.7811.4115.4510.247.310.56
Expenses 4.996.589.379.397.145.230.36
Operating Profit 0.956.202.046.063.102.080.20
OPM % 15.9948.5117.8839.2230.2728.4535.71
Other Income 0.250.640.690.510.290.100.00
Interest 0.430.470.450.390.350.370.04
Depreciation 0.470.460.500.330.290.260.02
Profit before tax 0.305.911.785.852.751.550.14
Tax % 46.6727.2429.7825.3026.9128.3921.43
Net Profit 0.164.301.264.372.021.130.10
EPS in Rs 0.154.161.224.231.961.10β€”
Dividend Payout % 0.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Sep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Equity Capital 10.3410.3410.3410.3410.344.704.700.01
Reserves 9.019.429.274.973.694.962.940.10
Borrowings 4.905.074.174.572.031.001.091.36
Other Liabilities 9.5210.738.288.527.004.823.646.34
Total Liabilities 33.7735.5632.0628.4023.0615.4812.377.81
Fixed Assets 3.784.014.474.623.502.992.842.91
CWIP 0.140.140.140.140.120.000.000.00
Investments 0.110.110.110.110.110.000.000.00
Other Assets 29.7431.3027.3423.5319.3312.499.534.90
Total Assets 33.7735.5632.0628.4023.0615.4812.377.81

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Cash from Operating Activity 0.250.752.325.792.871.512.99
Cash from Investing Activity 0.230.33-0.94-4.23-1.10-3.96-2.92
Cash from Financing Activity 0.49-0.86-0.370.67-0.392.550.96
Net Cash Flow 0.970.221.012.231.380.101.03
Free Cash Flow 0.240.440.694.832.441.320.06
CFO/OP % 29.0012.00115.00107.00102.0084.001,495.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debtor Days 374.22137.37103.9742.0573.0778.39860.36
Inventory Days β€”β€”β€”β€”β€”β€”4,380.00
Days Payable β€”β€”β€”β€”β€”β€”5,266.43
Cash Conversion Cycle 374.22137.37103.9742.0573.0778.39-26.07
Working Capital Days -46.70-68.83-160.27-31.42-53.82-42.44-2,887.41
ROCE % 3.0029.2312.4146.7131.9837.65β€”

Shareholding Pattern

% holding β€” latest first
Holder Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 30.17 32.09 32.09 32.09 32.09 32.09 31.99 32.82 48.47 51.73 53.10 53.10
Public 69.82 67.89 67.91 67.89 67.90 67.91 68.01 67.18 51.53 48.26 46.90 46.90
No. of Shareholders 4,243 4,217 4,285 4,363 4,382 4,298 3,863 3,349 2,426 2,092 2,098 1,336

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Bonus 29 Mar 2022 30 Mar 2022 6:5 β€”

Announcements

5 filings